Regeneron Pharmaceuticals, Inc.
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
Last updated:
Abstract:
The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
Status:
Grant
Type:
Utility
Filling date:
27 Jun 2018
Issue date:
20 Oct 2020